Orthopedic splints market seen reaching $3.52 billion by 2030

The Business Research Company says the global orthopedic splints market will grow from $2.3 billion in 2025 to $2.51 billion in 2026, then reach $3.52 billion by 2030. Rising musculoskeletal disorders, sports injuries and demand for outpatient and home recovery care are among the main growth drivers.

Why it matters: - The orthopedic splints market is tied directly to injury recovery and musculoskeletal care. - Growth in fractures, sports injuries and long-term mobility problems is expanding demand for immobilization and support devices. - The market’s projected rise to $3.52 billion by 2030 signals steady demand across hospitals, emergency care, ambulatory services and home recovery.

What happened: - The Business Research Company released a report on the global orthopedic splints market on Aug. 21, 2026. - The report says the market will rise from $2.3 billion in 2025 to $2.51 billion in 2026. - The report projects the market will reach $3.52 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Orthopedic splints support, stabilize or immobilize injured bones, joints or soft tissues to help healing. - Splints can be custom-molded to a patient’s anatomy or prefabricated for easier application and a consistent fit. - Historical growth has been driven by more fracture cases, expanded emergency care, higher sports participation, growth in hospital trauma facilities and wider availability of ready-to-use splints. - Future growth is expected to come from more ambulatory care services, demand for affordable immobilization methods, innovations in splint materials, injuries among older adults and growth in home recovery care. - Reported market trends include stronger preference for prefabricated splints, more use in sports injury treatment, broader adoption in emergency medical care, lighter-weight materials and expansion of outpatient orthopedic services. - The report also breaks out the market across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report cites a January 2024 Gov.UK update showing long-term musculoskeletal conditions among people aged 16 and above in the UK rose from 17.6% in 2022 to 18.4% in 2023. - The same Gov.UK data showed prevalence was higher among females at 20.9% than males at 15.8%. - The company also highlighted expanded 2026 report features, including market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - More information is available in the full report and a free sample.

Between the lines: - The report points to a market shaped less by elective demand and more by everyday clinical need, especially as musculoskeletal conditions and aging-related injuries rise. - The faster growth forecast for Asia-Pacific suggests the strongest expansion may come from regions where healthcare access, trauma care and outpatient treatment capacity are still growing. - The preference for prefabricated and lightweight splints suggests buyers are prioritizing speed, convenience and lower-cost recovery settings.

What's next: - Demand should keep rising as ambulatory care and home recovery become more common. - Product innovation around materials and fit is likely to remain a key competitive theme. - Regional growth outside North America could narrow the market gap over the next several years.

The bottom line: - Orthopedic splints are becoming a bigger part of routine recovery care, and the market is set for sustained growth through 2030.